Medical device firm in the cardiology space
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | HEARTFLOW, INC. |
1st Quarter (Jan 1 - Mar 31) AMENDED |
$90,000 | |
| 2026 | HEARTFLOW, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$60,000 | |
| 2025 | HEARTFLOW, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$90,000 | |
| 2025 | HEARTFLOW, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$90,000 | |
| 2025 | HEARTFLOW, INC. |
2nd Quarter (Apr 1 - June 30) AMENDED |
$90,000 | |
| 2025 | HEARTFLOW, INC. |
3rd Quarter (July 1 - Sep 30) AMENDED |
— | |
| 2025 | HEARTFLOW, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination |
$90,000 | |
| 2025 | HEARTFLOW, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$90,000 | |
| 2025 | HEARTFLOW, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$90,000 | |
| 2024 | HEARTFLOW, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$80,000 |
| Firm | Filings | Expenses |
|---|---|---|
| HEARTFLOW, INC. | 21 | $1,510,000 |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 20 |
| Health Issues | 2 |
| Budget/Appropriations | 1 |
| Medical/Disease Research/Clinical Labs | 1 |
| Science/Technology | 1 |